Larvol Delta - Trial-in-Progress-ANCHOR--Phase-2-Randomized-DoubleBlind-PlaceboControlled-Study-to-Evaluate-the-Efficacy-and-Safety-of-ABBVCLS628-in-ADPKD

ABBV-CLS-628 - AbbVie, Calico Life Sciences

https://pagv3.virtual-meeting.org/era/era26/en-GB/pag/presentation/507136?guestPreview=1

Maureen Horton

Apr 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next